Baker Brothers Life Sciences LP, Director, 10% Owner at GENOMIC HEALTH INC (GHDX), sold 97,200 shares at $85.87 ($8.1M) on 2018-11-09, disclosed to the SEC on 2018-11-13.
Open-market sale of $8.1M GHDX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $82.00 | 71 | $6K | 0.1% |
| 2 | $82.00 | 5 | $410 | 0.0% |
| 3 | $82.00 | 109 | $9K | 0.1% |
| 4 | $82.00 | 63 | $5K | 0.1% |
| 5 | $83.20 | 62,929 | $5.2M | 64.3% |
| 6 | $83.20 | 74 |
| $6K |
| 0.1% |
| 7 | $83.20 | 966 | $80K | 1.0% |
| 8 | $83.20 | 1,078 | $90K | 1.1% |
| 9 | $83.20 | 9,661 | $804K | 9.9% |
| 10 | $83.90 | 109 | $9K | 0.1% |
| 11 | $83.90 | 633 | $53K | 0.7% |
| 12 | $83.90 | 5 | $420 | 0.0% |
| 13 | $83.90 | 63 | $5K | 0.1% |
| 14 | $83.90 | 71 | $6K | 0.1% |
| 15 | $85.87 | 21 | $2K | 0.0% |
| 16 | $85.87 | 17,602 | $1.5M | 18.6% |
| 17 | $85.87 | 270 | $23K | 0.3% |
| 18 | $85.87 | 302 | $26K | 0.3% |
| 19 | $85.87 | 466 | $40K | 0.5% |
| 20 | $85.87 | 2,702 | $232K | 2.8% |
| Total | $83.79 avg | 97,200 | $8.1M | 100% |
| Filing → |
| IGMS | BUY | 2023-12-15 | $5.4M | — | Filing → |
| MDGL | BUY | 2023-11-21 | $22.1M | — | Filing → |
| BGNE | SELL | 2023-11-14 | $198.6M | — | Filing → |